Qrons Inc
First Person Ltd., through its subsidiaries, engages in the formulation and distribution of wholesale food grade functional mushrooms and cognitive performance products focusing on the mental performance and wellness markets in the United States. It focuses on the research and development of psilocybin mushrooms. The company is headquartered in Calgary, Canada.
Market Cap & Net Worth: Qrons Inc (QRON)
Qrons Inc (OTCQB:QRON) has a market capitalization of $2.70 Million ($2.70 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #39451 globally and #12850 in its home market, demonstrating a -7.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Qrons Inc's stock price $0.15 by its total outstanding shares 18000000 (18.00 Million).
Qrons Inc Market Cap History: 2017 to 2025
Qrons Inc's market capitalization history from 2017 to 2025. Data shows change from $50.40 Million to $2.70 Million (-22.18% CAGR).
Qrons Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Qrons Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of QRON by Market Capitalization
Companies near Qrons Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Qrons Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Qrons Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, Qrons Inc's market cap moved from $50.40 Million to $ 2.70 Million, with a yearly change of -22.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.70 Million | -6.83% |
| 2024 | $2.90 Million | -30.00% |
| 2023 | $4.14 Million | -54.90% |
| 2022 | $9.18 Million | -36.25% |
| 2021 | $14.40 Million | +105.13% |
| 2020 | $7.02 Million | -18.75% |
| 2019 | $8.64 Million | -79.13% |
| 2018 | $41.40 Million | -17.86% |
| 2017 | $50.40 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Qrons Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.70 Million USD |
| MoneyControl | $2.70 Million USD |
| MarketWatch | $2.70 Million USD |
| marketcap.company | $2.70 Million USD |
| Reuters | $2.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.